2024 Rome, Italy

IV-092 Yin Cheong Wong
Population pharmacokinetic/pharmacodynamic modeling to evaluate target suppression in patients with advanced solid tumors by ginisortamab, an anti-gremlin-1 monoclonal antibody
Thursday 15:00-16:30